WHO alert, 9 March 2022
N°2/2022: Falsified DESREM (remdesivir) injection
Last checked 20 September 2026
The WHO warned on 9 March 2022 that falsified DESREM, a remdesivir injection used for COVID-19, had been identified in India and Guatemala. The genuine product is manufactured by Mylan Laboratories in India; the falsified vials carried Mylan's branding but were not made by the company and were not authorised for supply. The alert asked national regulators and health workers to check batch details against the genuine manufacturer's records and to report suspect products.
India link: Falsified vials found in India and Guatemala; the genuine product is made in India by Mylan
WHO Medical Product Alert N°2/2022: Falsified DESREM (remdesivir)
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Products named
- DESREM (remdesivir) 100 mg injection, falsified
- Genuine product: Mylan Laboratories, India
Official sources and primary records
- WHO
- WHO